WebJun 15, 2024 · Finerenone (BAY 94-8862) is an investigational, non-steroidal, selective mineralocorticoid receptor antagonist that has been shown to block the harmful effects of the overactivated mineralocorticoid receptor (MR) system. MR overactivation is a major driver of heart and kidney damage. 3 WebClinical trials are studies to test new drugs, already approved drugs, devices, or other forms of treatments. Many clinical trials look at new ways to detect, diagnose, or measure the extent of disease. Some even look at ways to prevent diseases from happening. Researchers still use human volunteers to test these methods, and the same rules apply.
How Finerenone Compares to Other Mineralocorticoid Receptor …
WebMar 22, 2024 · Interventional (Clinical Trial) Estimated Enrollment : 18200 participants: Allocation: Randomized: Intervention Model: Parallel Assignment: Masking: Quadruple … WebContact: 443-546-1400. Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) … manitoba teachers society discounts
Finerenone Reduces Risk of Incident Heart Failure in Patients With ...
WebIn the FINEARTS-HF-study the effectiveness and safety of finerenone will be investigated in heart failure patients with mildly impaired heart function and compared to placebo. … WebNov 13, 2024 · Study to evaluate the efficacy (effect on disease) and safety of finerenone on morbidity (events indicating disease worsening) and mortality (death rate) in participants … WebAdditional clinical trials are underway and will help define the role of finerenone in other disease states; these include FINEARTS-HF in patients with HF and LVEF of ≥40%, FIND-CKD in patients with non-diabetic CKD, and CONFIDENCE in patients with CKD in … korumburra gun club facebook